Becker's ASC Review

31 HEALTHCARE NEWS CEO Pay at the 20 Largest Healthcare Companies by Revenue By Ayla Ellison M any of the highest earners among organizations in the Standard & Poor's 500 index are healthcare sec- tor CEOs, according to a report from Equilar, a provider of executive, board and gover- nance data solutions. Each year, Equilar examines CEO pay at the 100 largest companies by revenue that file proxy statements before April 1. Among CEOs in the Equilar 100, average pay totaled $16.6 million in fiscal year 2016 and total compensation climbed a median of 6 percent from the year prior. "is year's increase in CEO pay was the larg- est acceleration we've seen for this study since 2013," said Dan Marcec, director of content at Equilar. "While most of these awards were granted well before the presidential election, the bullish market in 2016 seems to have had a positive influence on compensation design." Twenty companies in the healthcare sec- tor are included on this year's Equilar 100. Each of these companies is listed below along with their CEO's total compensation for FY 2016. Total compensation includes informa- tion disclosed in company proxy statements, including salary, bonus, stock and options valued at grant date, and other compensa- tion disclosed in the summary compensation table of the proxy statements. Total compen- sation does not include pension and deferred compensation values. 1. Michael F. Neidorff, Centene (St. Louis) — $21.97 million 2. Alex Gorsky, Johnson & Johnson (New Brunswick, N.J.) — $21.21 million 3. Pierre Nanterme, Accenture (Dublin, Ireland) — $18.5 million 4. Larry J. Merlo, CVS Health (Woonsocket, R.I.) — $18.36 million 5. Richard A. Gonzalez, AbbVie (North Chi- cago, Ill.) — $17.74 million 6. Ian C. Read, Pfizer (New York City) — $16.99 million 7. Giovanni Caforio, Bristol-Myers Squibb (New York City) — $16.93 million 8. Joseph R. Swedish, Anthem (Indianapolis) — $16.46 million 9. Miles D. White, Abbott Laboratories (Chi- cago) — $16.42 million 10. John C. Lechleiter, Eli Lilly (Indianapolis) — $15.22 million 11. David M. Cordani, Cigna (Bloomfield, Conn.) — $15.21 million 12. Timothy Wentworth, Express Scripts (St. Louis) — $14.52 million 13. John F. Milligan, Gilead Sciences (Foster City, Calif.) — $13.94 million 14. omas J. Falk, Kimberly-Clark (New York City) — $13.76 million 15. George S. Barrett, Cardinal Health (Dub- lin, Ohio) — $13.66 million 16. Bruce D. Broussard, Humana (Louisville, Ky.) — $12.21 million 17. R. Milton Johnson, HCA Holdings (Nash- ville, Tenn.) — $11.83 million 18. Trevor Fetter, Tenet Healthcare (Dallas) — $10.14 million 19. Stefano Pessina, Walgreens Boots Alliance (Deerfield, Ill.) — $10.14 million 20. J. Mario Molina, MD, Molina Healthcare (Long Beach, Calif.) — $9.88 million n What Kaiser Permanente CEO Bernard Tyson Learned as a Patient in His Own Hospital By Tamara Rosin W hen Bernard Tyson, chairman and CEO of Oakland, Calif.-based Kaiser Permanente, knew something didn't feel right, he called his cardiologist imme- diately and went straight to the emergency room. There, he experienced firsthand what happens in a Kaiser ER. "In that moment where your health is on the line, it doesn't matter what position you hold or what resources you have or don't have. The important things that matter are being able to continue living your life and overcoming all of your fears when your body isn't acting normally. It was scary and I was scared," Mr. Tyson, who heads the 38-hospital non- profit system and health plan with more than 11.3 mem- bers, wrote in a LinkedIn post about his experience receiv- ing care from the health system he leads. Mr. Tyson explained that since having heart surgery 11 years ago, he has worked hard to improve his health. Now, finding himself back in the ER, Mr. Tyson put himself in the hands of Kaiser's physicians and nurses. After X-rays, an ul- trasound and other tests, the team of clinicians identified the issue and stabilized him. "My prognosis depended on the ability of my physicians to guide me — both mentally and physically — through an explanation of what was happening in my body and the options that were available to me," wrote Mr. Tyson. The next week Mr. Tyson would require another heart pro- cedure. There, "I experienced firsthand the medical excel- lence we deliver." He said the interventional cardiologist he met with was "incredible." "The way he described what he was going to do and how he would do it made me feel like I was meeting with an art- ist — and perhaps this is the highest level of art and science one can do because it sustains life," he wrote. "The proce- dure went exceptionally well. They were able to go into my

• Cover